Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. Far fewer people who could benefit from statins ...

A new Lancet study says statin side effects are overblown. Headlines are running that millions more people should be taking ...

EAST HANOVER, N.J., April 6, 2024 /PRNewswire/ -- Novartis today announced new data demonstrating the early addition of twice-yearly* Leqvio ® (inclisiran) to maximally tolerated statin therapy, prior ...

Statin use is linked to better survival in breast cancer, observational data from Taiwan suggest. Yet researchers only saw a difference for all-cause and cancer-related deaths, not CV death. The ...

Statins, which are prescription drugs that can reduce cholesterol levels and lower the risk for heart disease, don’t affect kidney function, new research shows. Investigators found that taking a ...

Doctor’s personal choice: Cardiologist Christopher Kelly began taking statins in his 30s despite only moderately elevated cholesterol, citing family history and prevention data. Global tool validated: ...

There’s a more accurate way of measuring who’s at risk for cholesterol-related health issues. So why don’t more doctors use ...

Patel is a board-certified emergency medicine physician, former U.S. Navy flight surgeon, and founder of MD Longevity Lab. A patient came to my office recently and told me she had stopped her statin.

HKUMed demonstrates that statins can lower the risk of cardiovascular disease without increasing major adverse events, providing guidance for future clinical practice in managing high cholesterol. The ...

The polypill offers a cost-effective solution for CVD management in underserved populations, potentially reducing health disparities. The intervention is projected to cost $8560 per QALY gained, ...